TXNIP and neoplasm: Consistent with these observations, the TRAMP PCa mouse model showed a reduction in TXNIP at both RNA and protein level during tumor progression when compared with their WT counterparts at 32 and 44 weeks (Figs. 1F–I, and S1A).